2024
Preclinical Studies Completion
LignaMed expects to complete preclinical studies for LGM2605 as device in lung transplant in 2024
LignaMed plans to submit device package for lung transplant in 2024
Submit IND Application to FDA
An IND submission for asthma is planned for 2024
2025
Clinical Studies
Initiation of clinical studies for asthma is planned for 2025
Completion of clinical studies for device is planned for 2025